Financhill
Buy
75

VEEV Quote, Financials, Valuation and Earnings

Last price:
$279.70
Seasonality move :
12.49%
Day range:
$273.33 - $280.87
52-week range:
$170.25 - $285.70
Dividend yield:
0%
P/E ratio:
59.26x
P/S ratio:
16.22x
P/B ratio:
7.34x
Volume:
3.6M
Avg. volume:
1.4M
1-year change:
44.03%
Market cap:
$45.6B
Revenue:
$2.7B
EPS (TTM):
$4.72

VEEV Analysts' Consensus Rating

The 24 analysts providing 12-month price projections for Veeva Systems shares anticipate an average target of $286.65, ranging from a low estimate of $210.00 to a high estimate of $335.00. This average target implies a growth of 2.49% compared to the current stock price of $279.70.

Consensus Price Target

$286.65

Highest Price Target

$335.00

Lowest Price Target

$210.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 10 13 12

Hold 9 9 11

Sell 1 1 1
Consensus Buy Buy Buy

VEEV Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Where Will Asana Stock Be in 5 Years?
Where Will Asana Stock Be in 5 Years?

Asana stock hasn’t given many investors on Wall Street any…

Where Will Dell Stock Be in 5 Years?
Where Will Dell Stock Be in 5 Years?

So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock